Latest Cash Flow News

UOA Development Bhd reported a striking surge in first quarter 2025 revenue and profit, driven by strong sales and ongoing project progress. The company’s robust unbilled sales pipeline signals sustained growth ahead.

Top Shelf International Holdings has resolved its long-standing excise debt issue, leading to the dismissal of Australian Taxation Office proceedings against its subsidiary.

CAQ Holdings Limited has successfully restructured its debt repayment schedule and secured a new RMB 6 million loan facility, positioning itself to support operational growth amid efforts to increase occupancy rates.

Fisher & Paykel Healthcare has announced an ordinary dividend of NZD 0.28235294 per share for the six months ending March 31, 2025, payable on July 4. The dividend is unfranked and includes a supplementary component, with a 15% withholding tax applied.

IPD Group Limited forecasts a modest decline in earnings for FY25, even as revenue grows across key segments and cash flow remains robust.

Yancoal Australia Ltd reported robust 2024 financial results and outlined key corporate governance actions at its 2025 Annual General Meeting, reinforcing its position as a leading coal producer amid market challenges.

Web Travel Group Limited reported a robust 22% increase in Total Transaction Value for FY25, despite a 14% dip in EBITDA due to margin pressures and higher costs. The company is strategically investing in supply and technology to target $10 billion TTV by FY30.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

Smartpay has reported an 8.5% rise in consolidated revenue for FY2025, driven by growth in Australia and a bold entry into New Zealand’s acquiring market. However, investments in technology and market expansion have weighed on EBITDA.

Xanadu Mines Limited has received a conditional off-market takeover offer from Bastion Mining Pte Ltd at A$0.08 per share, representing a significant premium. The company’s independent Takeover Committee unanimously recommends acceptance, supported by an independent expert’s fair and reasonable valuation.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

Barton Gold Holdings has raised $3 million through a premium-priced placement to fast-track resource upgrade drilling at its Tunkillia Gold Project, boosting its cash reserves to $9 million with minimal dilution.